在体外和体内模型来研究角膜内皮-间充质转换
Özet
牛角膜内皮细胞的原代培养物用于研究角膜内皮 – 间充质转换的机制。此外，大鼠角膜内皮冷冻损伤模型被用来证明在体内角膜内皮-间充质转换。
Abstract
Corneal endothelial cells (CECs) play a crucial role in maintaining corneal clarity through active pumping. A reduced CEC count may lead to corneal edema and diminished visual acuity. However, human CECs are prone to compromised proliferative potential. Furthermore, stimulation of cell growth is often complicated by gradual endothelial-mesenchymal transition (EnMT). Therefore, understanding the mechanism of EnMT is necessary for facilitating the regeneration of CECs with competent function. In this study, we prepared a primary culture of bovine CECs by peeling the CECs with Descemet’s membrane from the corneal button and demonstrated that bovine CECs exhibited the EnMT process, including phenotypic change, nuclear translocation of β-catenin, and EMT regulators snail and slug, in the in vitro culture. Furthermore, we used a rat corneal endothelium cryoinjury model to demonstrate the EnMT process in vivo. Collectively, the in vitro primary culture of bovine CECs and in vivo rat corneal endothelium cryoinjury models offers useful platforms for investigating the mechanism of EnMT.
Introduction
Corneal endothelial cells (CECs) play a vital role in maintaining corneal clarity and thus visual acuity by regulating the hydration status of the corneal stroma through active pumping1. Because of the limited proliferative potential of human CECs, the cell number decreases with age, and the repair of corneal endothelial wounds following injury is usually achieved through cell enlargement and migration, rather than cell mitosis2. When the CEC count decreases below a threshold of approximately 500 cells/mm2, the dehydration status of the corneal stroma cannot be maintained, leading to bullous keratopathy and vision impairment3,4.
The limited proliferative potential of human CECs has been attributed to several factors, including reduced expression of the epidermal growth factor and its receptor in aging cells5, antiproliferative TGFβ2 in the aqueous humor6, and contact inhibition2,7. Although some growth factors, such as basic fibroblast growth factor (bFGF), can increase proliferation in a cultured human corneal endothelium, the culture efficiency remains limited8,9. Furthermore, CECs may undergo a phenotypic change during ex vivo expansion, resembling epithelial-mesenchymal transition (EMT)10-13. Endothelial-mesenchymal transition (EnMT) is characterized by cell junction destabilization, apical-basal polarity loss, cytoskeletal rearrangement, alpha smooth muscle actin expression, and type I collagen secretion14. All of these characteristics may abrogate the normal function of CECs, hampering the use of ex vivo cultured CECs in tissue engineering. Moreover, EnMT has been associated with the pathogenesis of several corneal endothelial diseases, including Fuchs endothelial corneal dystrophy and retrocorneal membrane formation15,16. Therefore, understanding the mechanism of EnMT may aid in manipulating the EnMT process and facilitate the regeneration of CECs to enable competent function.
In this study, we described a method for isolating bovine CECs from the corneal button. In the primary culture in vitro, the EnMT process, including a phenotypic change, the nuclear translocation of β-catenin, and EMT regulators snail and slug, was observed. We further described a method for demonstrating EnMT in vivo by using a rat corneal endothelium cryoinjury model. Using these 2 models, we demonstrated that marimastat, a broad-spectrum matrix metalloproteinase (MMP) inhibitor, can suppress the EnMT process. The described protocols facilitate the detailed analysis of the EnMT mechanism and the development of strategies for manipulating the EnMT process for further clinical application.
Protocol
Representative Results
Discussion
的CEC是众所周知的倾向中的细胞增殖经受EnMT。制定战略用于抑制EnMT过程用于治疗目的时，EnMT机构的透彻理解是必要的。我们描述了2模型，研究EnMT，即在体 外培养模型大鼠角膜内皮冷冻损伤模型牛CEC。我们的研究结果证明了这两款车型的EnMT过程。此外，马立马司他的EnMT抑制效应再现这两种模式，这表明这些2种型号共享相同的机制。
体外培养模型牛CEC提?…
Açıklamalar
The authors have nothing to disclose.
Acknowledgements
We thank the staff of the Second Core Lab, Department of Medical Research, National Taiwan University Hospital for their technical support.
Materials
| trypsin | ThermoFisher Scientific | 12604-013 | |
| Dulbecco’s modified Eagle medium and Ham's F12 medium | ThermoFisher Scientific | 11330 | |
| fetal bovine serum | ThermoFisher Scientific | 26140-079 | |
| dimethyl sulfoxide | Sigma | D2650 | |
| human epidermal growth factor | ThermoFisher Scientific | PHG0311 | |
| insulin, transferrin, selenium | ThermoFisher Scientific | 41400-045 | |
| cholera toxin | Sigma | C8052-1MG | |
| gentamicin | ThermoFisher Scientific | 15750-060 | |
| amphotericin B | ThermoFisher Scientific | 15290-026 | |
| paraformaldehyde | Electron Microscopy Sciences | 111219 | |
| Triton X-100 | Sigma | T8787 | |
| bovine serum albumin | Sigma | A7906 | |
| marimastat | Sigma | M2699-25MG | |
| anti-active beta-catenin antibody | Millpore | 05-665 | |
| anti-snail antibody | Santa cruz | sc28199 | |
| anti-slug antibody | Santa cruz | sc15391 | |
| goat anti-mouse IgG (H+L) secondary antibody | ThermoFisher Scientific | A-11001 | for staining of ABC of bovine CECs |
| goat anti-mouse IgG (H+L) secondary antibody | ThermoFisher Scientific | A-11003 | for staining of ABC of rat corneal endothelium |
| goat anti-rabbit IgG (H+L) secondary antibody | ThermoFisher Scientific | A-11008 | for staining of snail and slug of bovine CECs |
| antibody diluent | Genemed Biotechnologies | 10-0001 | |
| 4',6-diamidino-2-phenylindole | ThermoFisher Scientific | D1306 | |
| mounting medium | Vector Laboratories | H-1000 | |
| laser scanning confocal microscope | ZEISS | LSM510 | |
| xylazine | Bayer | N/A | |
| tiletamine plus zolazepam | Virbac | N/A | veterinary drug |
| proparacaine hydrochloride ophthalmic solution | Alcon | N/A | veterinary drug |
| 0.1% atropine | Wu-Fu Laboratories Co., Ltd | N/A | clinical drug |
| 0.3% gentamicin sulfate | Sinphar Group | N/A | clinical drug |
| basic fibroblast growth factor | ThermoFisher Scientific | PHG0024 | clinical drug |
Referanslar
- Maurice, D. M. The location of the fluid pump in the cornea. J Physiol. 221 (1), 43-54 (1972).
- Joyce, N. Proliferative capacity of the corneal endothelium. Progress in Retinal and Eye Research. 22 (3), 359-389 (2003).
- Morishige, N., Sonoda, K. H. Bullous keratopathy as a progressive disease: evidence from clinical and laboratory imaging studies. Cornea. 32, 77-83 (2013).
- Bates, A. K., Cheng, H., Hiorns, R. W. Pseudophakic bullous keratopathy: relationship with endothelial cell density and use of a predictive cell loss model. A preliminary report. Curr Eye Res. 5 (5), 363-366 (1986).
- Wilson, S. E., Lloyd, S. A. Epidermal growth factor and its receptor, basic fibroblast growth factor, transforming growth factor beta-1, and interleukin-1 alpha messenger RNA production in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 32 (10), 2747-2756 (1991).
- Chen, K. H., Harris, D. L., Joyce, N. C. TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci. 40 (11), 2513-2519 (1999).
- Senoo, T., Obara, Y., Joyce, N. C. EDTA: a promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci. 41 (10), 2930-2935 (2000).
- Yue, B. Y., Sugar, J., Gilboy, J. E., Elvart, J. L. Growth of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci. 30 (2), 248-253 (1989).
- Peh, G. S., Beuerman, R. W., Colman, A., Tan, D. T., Mehta, J. S. Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview. Transplantation. 91 (8), 811-819 (2011).
- Zhu, C., Rawe, I., Joyce, N. C. Differential protein expression in human corneal endothelial cells cultured from young and older donors. Mol Vis. 14, 1805-1814 (2008).
- Ko, M. K., Kay, E. P. Regulatory role of FGF-2 on type I collagen expression during endothelial mesenchymal transformation. Invest Ophthalmol Vis Sci. 46 (12), 4495-4503 (2005).
- Lee, H. T., Kay, E. P. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells. Mol Vis. 9, 624-634 (2003).
- Pipparelli, A., et al. ROCK Inhibitor Enhances Adhesion and Wound Healing of Human Corneal Endothelial Cells. PloS one. 8 (4), e62095 (2013).
- Roy, O., Leclerc, V. B., Bourget, J. M., Theriault, M., Proulx, S. Understanding the process of corneal endothelial morphological change in vitro. Invest Ophthalmol Vis Sci. 56 (2), 1228-1237 (2015).
- Jakobiec, F. A., Bhat, P. Retrocorneal membranes: a comparative immunohistochemical analysis of keratocytic, endothelial, and epithelial origins. Am J Ophthalmol. 150 (2), 230-242 (2010).
- Okumura, N., et al. Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy. Lab Invest. 95 (11), 1291-1304 (2015).
- Okumura, N., et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 50 (8), 3680-3687 (2009).
- Zhu, Y. T., Chen, H. C., Chen, S. Y., Tseng, S. C. G. Nuclear p120 catenin unlocks mitotic block of contact-inhibited human corneal endothelial monolayers without disrupting adherent junctions. J Cell Sci. 125 (15), 3636-3648 (2012).
- Ho, W. T., et al. Inhibition of Matrix Metalloproteinase Activity Reverses Corneal Endothelial-Mesenchymal Transition. Am J Pathol. 185 (8), 2158-2167 (2015).
- Kay, E. D., Cheung, C. C., Jester, J. V., Nimni, M. E., Smith, R. E. Type I collagen and fibronectin synthesis by retrocorneal fibrous membrane. Invest Ophthalmol Vis Sci. 22 (2), 200-212 (1982).
- Li, C., et al. Notch Signal Regulates Corneal Endothelial-to-Mesenchymal Transition. Am J Pathol. 183 (3), 786-795 (2013).
- Okumura, N., et al. The ROCK Inhibitor Eye Drop Accelerates Corneal Endothelium Wound Healing. Invest Ophthalmol Vis Sci. 54 (4), 2493-2502 (2013).
- Mannermaa, E., Vellonen, K. S., Urtti, A. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev. 58 (11), 1136-1163 (2006).
